| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | NPK76-II-72-1 | GDSC1000 | pan-cancer | AAC | 0.12 | 0.001 |
| mRNA | Obatoclax Mesylate | GDSC1000 | pan-cancer | AAC | -0.14 | 0.001 |
| mRNA | Cetuximab | GDSC1000 | pan-cancer | AAC | -0.13 | 0.001 |
| mRNA | GNF-2 | GDSC1000 | pan-cancer | AAC | -0.2 | 0.001 |
| mRNA | Cyclopamine | FIMM | pan-cancer | AAC | 1.2 | 0.001 |
| mRNA | XMD14-99 | GDSC1000 | pan-cancer | AAC | 0.13 | 0.001 |
| mRNA | Nutlin-3a (-) | GDSC1000 | pan-cancer | AAC | -0.13 | 0.002 |
| mRNA | YK 4-279 | CTRPv2 | pan-cancer | AAC | 0.12 | 0.002 |
| mRNA | necrosulfonamide | CTRPv2 | pan-cancer | AAC | 0.13 | 0.002 |
| mRNA | STF-62247 | GDSC1000 | pan-cancer | AAC | 0.12 | 0.002 |